What if you could spot stocks early—before they become the talk of the market? Investors often chase fundamentally strong ...
The interaction with GSK goes deeper, with Novartis and GSK announcing a merger of their OTC divisions to create a new joint venture which will be number one in the sector. This mirrors an earlier ...
Me files for bankruptcy, CEO Wojcicki resigns. James Hardie to acquire AZEK for $8.75B in cash, stock. Korean AI chip startup ...
Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...
Despite the company filing for bankruptcy, the co-founder won’t give up on her dream of using DNA kits to discover new drugs ...
The possibility of new ownership over 23andMe has some customers concerned about how their sensitive genetic information will ...
During the restructuring process, 23andMe obtained up to $35 million in debtor-in-possession finance to assist operations as ...
Me has tested more than 15m people’s genetic makeup using post-in saliva kits – including more than 250,000 in the UK - ...
Me's drugs and patents — including two possible deals — could be key to its exit out of Chapter 11 bankruptcy protection.
Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim CEO NEWTOWN, Pa., March 28, 2025 (GLOBE NEWSWIRE) -- Traws ...
23andMe cofounder and CEO Anne Wojcicki stepped down and the company filed for Chapter 11 bankruptcy protection, it said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results